NewsUpdate
Motilal Oswal Recommends BUY on PPL Pharma with Target Price of Rs 260
Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.
b
bigbreakingwire
9/30/2024 5 min read
— Sponsored —
— Sponsored —
Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.
— Sponsored —
Related News
Update
Air India AI-171 Crash Probe Advances, Final Report Pending
6/13/2026
Update
RBI Strengthens Cooperative Banks with Priority Sector Lending Reforms, Digital Push and Governance Changes
2/16/2026
Update
India’s Forex Reserves Drop to $717 Billion as Gold and FX Assets Decline: RBI Data
2/15/2026
Update
RBI Tightens Lending Rules to Brokers: Fully Secured Loans Mandatory from April 1, 2026
2/15/2026
Update
India-EU FTA Digital Trade Chapter to Boost Paperless Trade, e-Invoicing and Secure Cross-Border Transactions
2/14/2026
Update
AI Fears Trigger Sharp IT Stock Correction, JPMorgan Says Concerns Overstated
2/13/2026
More Recommendations
— Sponsored —